ACP Journal Club. Telaprevir combination therapy induced a sustained virologic response in nonresponsive chronic HCV infection
- PMID: 20713786
- DOI: 10.7326/0003-4819-153-4-201008170-02007
ACP Journal Club. Telaprevir combination therapy induced a sustained virologic response in nonresponsive chronic HCV infection
Comment on
-
Telaprevir for previously treated chronic HCV infection.N Engl J Med. 2010 Apr 8;362(14):1292-303. doi: 10.1056/NEJMoa0908014. N Engl J Med. 2010. PMID: 20375406 Clinical Trial.
Similar articles
-
Telaprevir: a hepatitis C NS3/4A protease inhibitor.Clin Ther. 2012 Sep;34(9):1857-82. doi: 10.1016/j.clinthera.2012.07.011. Epub 2012 Aug 28. Clin Ther. 2012. PMID: 22951253 Review.
-
[Chronic hepatitis C].Dtsch Med Wochenschr. 2010 Dec;135(50):2525-34; quiz 2535-8. doi: 10.1055/s-0030-1269423. Epub 2010 Dec 7. Dtsch Med Wochenschr. 2010. PMID: 21140330 Review. German.
-
Telaprevir: hope on the horizon, getting closer.Clin Liver Dis. 2009 Aug;13(3):441-52. doi: 10.1016/j.cld.2009.05.009. Clin Liver Dis. 2009. PMID: 19628160 Review.
-
A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response.J Infect Dis. 2001 Aug 15;184(4):405-9. doi: 10.1086/322778. Epub 2001 Jul 16. J Infect Dis. 2001. PMID: 11471097 Clinical Trial.
-
[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].Harefuah. 2012 Dec;151(12):709-14, 719. Harefuah. 2012. PMID: 23330266 Hebrew.
Publication types
LinkOut - more resources
Full Text Sources